Last edition
News about
Servier to Acquire KER-0193 from Kaerus Bioscience in Deal Worth Up to USD 450 Million
Servier has signed a definitive agreement to acquire KER-0193 from Kaerus Bioscience, a potential first-in-disease treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder.
Academically Global, a healthcare-focused EdTech platform, has unveiled PharmaHackers 2025, a first-of-its-kind international festival of knowledge and innovation for pharmacy students and professionals.
Mankind Pharma Gets CDSCO Nod to Begin Phase 1 Trials of Novel Autoimmune Drug Candidate MKP11093
Mankind Pharma Ltd., India’s 4th largest pharmaceutical company, today announced that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical trial of MKP11093, a novel, orally administered Janus kinase-1 (JAK-1) inhibitor.
Multiply Labs' UR-Powered Robotic Cluster Cut Cell and Gene Therapy Manufacturing Costs by 74%
Multiply Labs has combined its robotic manufacturing platforms with Universal Robots’ cobots to make cell and gene therapy manufacturing faster, cheaper, and more reliable.
Dr Reddy's UK API Facility Receives Seven FDA Observations Following Inspection
Dr Reddy’s Laboratories has announced that its Active Pharmaceutical Ingredient (API) manufacturing facility in Mirfield, West Yorkshire, United Kingdom, has come under scrutiny from the United States Food and Drug Administration (FDA).
Universal Robots Names Technicon as Global Pharma Certified Solution Partner
Universal Robots (UR)'s long-time partner Technicon has officially become its global Certified Solution Partner (CSP) for the pharmaceutical industry.
APACMed MedTech Forum to Debut in India, Spotlighting Innovation and Healthcare Access
The APACMed MedTech Forum (MTF), Asia Pacific’s leading gathering of MedTech leaders organised by the Asia Pacific Medical Technology Association, will be held in India for the first time on 16 and 17 September in New Delhi.
Permira Targets USD 4 Billion Valuation for Cambrex Amid USA Manufacturing Drive
Permira acquired Cambrex in 2019 for approximately USD 2.4 billion. The company now generates about USD 225 million in adjusted annual earnings and operates 14 facilities worldwide, half of which are located in the USA.
Stronger Industry Collaboration Key to Next-Gen Pharma Innovation: ACG Group Chairman
ACG Group Chairman Ajit Singh has called for stronger industry collaboration to drive next-generation pharma innovation, while Dr. Govind Pandey emphasised that ‘Invent in India’ must be the next leap for pharma machinery.
Olympus Corporation, a global medical technology company dedicated to making lives healthier, safer and more fulfilling, has entered into an exclusive worldwide distribution agreement with MacroLux Medical Technology Co., Ltd. to provide a range of single-use urology products, including cystoscopes, ureteroscopes and suction access sheaths.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy